Home » Topics » Disease categories and therapies » Urology

Urology
RSS

FDA grants NX-001 orphan drug status for prevention of delayed kidney graft function

Aug. 19, 2010

Palatin Technologies reports phase I safety data on bremelanotide in ED

Aug. 18, 2010

Pfizer describes MR antagonist for diabetic nephropathy

Aug. 11, 2010

Mission Pharmacal launches Uribel capsules for symptoms of urinary tract conditions in U.S.

Aug. 11, 2010

Stellar Pharma and Inibsa sign agreement to distribute and sell Uracyst in Spain

Aug. 2, 2010

Antares reports phase III data on Anturol gel for overactive bladder

July 28, 2010

Auxilium provides update on Xiaflex in Peyronie's disease

July 14, 2010

Reata completes equity financing for second pivotal bardoxolone methyl trial

July 14, 2010

Weekly rituximab reduces proteinuria in idiopathic membranous nephropathy

July 13, 2010

FDA grants fast track and orphan drug designations to BB3

July 8, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...